 |
|
Scientists develop mathematical model to predict the immune response to influenza
May 14, 2009NIAID media availability
Researchers at the University of Rochester have developed a mathematical model to predict immune responses to infection with influenza A viruses, including novel viruses such as the emergent 2009 influenza A (H1N1). This model examines the contributions of specific sets of immune cells in fighting influenza A virus. The model also helps predict when during the immune response to viral infection antiviral therapy would be most effective.
The project was conducted by investigators funded through the Modeling Immunity for Biodefense program, a program established in 2005 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to improve preparedness for emerging and re-emerging pathogens.
When an individual is infected by a virus, a network of immune cells becomes immediately engaged, taking up viral particles and presenting pieces of the virus-antigens-to specialized white blood cells, thereby initiating a virus-specific response. The responding cells include T cells-which either directly attack and eliminate virus-infected cells or help other immune cells fight the virus-as well as B cells, which produce antibodies that bind and neutralize the virus.
The mathematical model developed by the research team generates immune response scenarios reflecting multiple variables, including the pathogenicity of the virus, numbers of responding B and T cells and function of antigen-presenting cells, in the lungs and lymph nodes. Their model suggests that prolonged viral infection limits the production of T cells and inhibits antigen presentation to immune cells. Confirming previous findings, the mathematical model predicts that antiviral therapy is most effective in reducing the spread of the virus when given within two days after infection.
The research team tested the accuracy of their model in mice infected with influenza A virus. They next plan to apply the model to human populations and continue to improve the model as more data become available.
In addition to the investigators in Rochester, NIAID supports three additional laboratories across the United States as part of the Modeling Immunity for Biodefense program. These scientists are conducting immune modeling research with the goal of developing models to simulate host immune responses to infections or vaccination in order to better treat and prevent diseases affecting millions of people, such as seasonal flu and tuberculosis.
NIH/National Institute of Allergy and Infectious Diseases
When an individual is infected by a virus, a network of immune cells becomes immediately engaged, taking up viral particles and presenting pieces of the virus-antigens-to specialized white blood cells, thereby initiating a virus-specific response. The responding cells include T cells-which either directly attack and eliminate virus-infected cells or help other immune cells fight the virus-as well as B cells, which produce antibodies that bind and neutralize the virus.
The mathematical model developed by the research team generates immune response scenarios reflecting multiple variables, including the pathogenicity of the virus, numbers of responding B and T cells and function of antigen-presenting cells, in the lungs and lymph nodes. Their model suggests that prolonged viral infection limits the production of T cells and inhibits antigen presentation to immune cells. Confirming previous findings, the mathematical model predicts that antiviral therapy is most effective in reducing the spread of the virus when given within two days after infection.
The research team tested the accuracy of their model in mice infected with influenza A virus. They next plan to apply the model to human populations and continue to improve the model as more data become available.
In addition to the investigators in Rochester, NIAID supports three additional laboratories across the United States as part of the Modeling Immunity for Biodefense program. These scientists are conducting immune modeling research with the goal of developing models to simulate host immune responses to infections or vaccination in order to better treat and prevent diseases affecting millions of people, such as seasonal flu and tuberculosis.
NIH/National Institute of Allergy and Infectious Diseases
Immune Cells Current Events and Immune Cells News RSSNew findings suggest strategy to help generate HIV-neutralizing antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Sweet -- sugared polymer a new weapon against allergies and asthma
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks.
Scientists visualize how bacteria talk to one another
Using imaging mass spectrometry, researchers at the University of California, San Diego have developed tools that will enable scientists to visualize how different cell populations of cells communicate.
Key player identified in cascade that leads to hypertension-related kidney damage
A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both.
Genetic links to fungal infection risk identified
Two genetic mutations that may put individuals at increased risk of fungal infections have been identified by scientists from UCL and Radboud University, increasing understanding about the genetic basis of these infections and potentially aiding the development of new treatments.
Study shows how carbon nanotubes can affect lining of the lungs
Carbon nanotubes are being considered for use in everything from sports equipment to medical applications, but a great deal remains unknown about whether these materials cause respiratory or other health problems.
Manipulating Brain Inflammation May Help Clear Brain of Amyloid Plaques, Mayo Clinic Researchers Say
In a surprising reversal of long-standing scientific belief, researchers at the Mayo Clinic campus in Florida have discovered that inflammation in the brain is not the trigger that leads to buildup of amyloid deposits and development of Alzheimer's disease.
Stanford study identifies cellular mechanism that causes lupuslike symptoms in mice
Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease.
New chromosomal abnormality identified in leukemia associated with Down syndrome
Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome.
Research shows treating HIV-AIDS with interleukin-2 is ineffective
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped.
More Immune Cells Current Events and Immune Cells News Articles
 |
Mechanisms of Lymphocyte Activation and Immune Regulation XI: B Cell Biology (Advances in Experimental Medicine and Biology) (v. 11) by Sudhir Gupta (Editor), Frederick W. Alt (Editor), Max D. Cooper (Editor), Fritz Melchers (Editor), Klaus Rajewsky (Editor) In recent years, major developments have been made in understanding various genetic and epigenetic regulatory processes that are critical for the generation of B cell repertoires. These include the role of chromatin regulation and nuclear organization in understating the IgH gene regulation. A role and mechanism of DNA repair proteins in somatic hypermutation has been elucidated. Genetic mutation studies have been instrumental in providing insight into some of the mechanisms involved in targeting CSR to various switch DNA regions located upstream of C region genes, especially a role of AID motifs, transcription, and R-loops. Recent studies support a dominant role of receptor editing in central B cell tolerance and signaling pathways that regulate receptor editing in self-reactive and... |
 |
Source Naturals Immune Defense, 16-Mushroom Complex, Tablets, 120 tablets by Source Naturals Dietary supplement. Source Naturals Mushroom Immune Defense is a blend of mushroom mycelia and extracts from 16 of the most well-studied species of health-supportive mushrooms. although the exact mechanisms of action in the body are not yet fully understood, researchers propose that constituents of these mushrooms may support natural killer (NK) cell, T-cell, and macrophage activity, and cytokine production. By carefully combining these mushrooms and fortifying them with extracts. Source Naturals Mushroom Immune Defense offers a broad-spectrum, high potency, complete mushroom product. (These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.) Suitable for vegetarians. Contains no yeast,... |
 |
Natural C-Cap Formula - Maintains overall cell health and supports your pets immune system Buy 2, Get 1 Free by PetAlive What are C-Caps? C-Caps contain a combination of especially selected herbs known for their immune tonic properties, ability to support vitality and health, and for their cleansing and purifying actions. Each supports health in all cells, tissues, and organs in the body. Many of these herbs have been used for centuries in traditional medicine and subjected to clinical research. |
 |
Mineralized Whey Protein Isolate - Muscle Cell Metabolism - 8oz Chocolate Flavor by Organic Essentials For Life |
 |
The Human Body: How We Fail, How We Heal Also With: Anthony A. Goodman (Primary Contributor) 12 lectures/30 minutes per lecture on 2 DVDs. Part 1 only of 2 parts. |
|
Cancer and the Immune System : Cell-to-Cell Communication, An Introduction (31 minute colour VHS video) (NTSC video) by Spektrum Videothek Produced in Germany. In English. "This documentary focuses on... findings in immunilogical research." | |
 |
Antiox-10, 90 Capsules by Vetri-Science A supplement for dogs to support immune system and circulatory functions, and skin health. ANTIOX, grape seed extract supplement is standardized to yield 95% proanthocyanidins (PCOs) per capsule. PCOs are a special class of water-soluble bioflavonoids that are potent antioxidants. In some comparative tests, PCOs were found to be 50 times more potent than Vitamin E and 20 times more potent than Vitamin C as antioxidants. PCOs normalize the release of histamine from mast cells. PCOs support capillary strength. Weak capillaries can contribute to bruising, elastin and collagen dysfunction, edema, and circulatory insufficiencies. |
 |
Guide to Signal Pathways in Immune Cells by E. Nigel Wardle (Author) In "Guide to Signal Pathways in Immune Cells", Nigel E. Wardle presents vital information in regards to white cells, like the neutrophils and macrophages, T and B lymphocytes, natural killer cells and mast cells, as they constitute the immune defenses against microbial invaders or tumor cells. In all such cells the necessary information processing for their activities utilizes a network of intracellular signaling pathways. As a guide this book aims to extend understanding of the basic signal transduction pathways that will be suitable for students of immunology or cell biology and for medical personnel at all levels. |
 |
The Extra Edge: Benefits of Immune-enhancing Enteral Formulas Also With: Novartis (Producer) Immune-enhancing enteral formulas provide critically ill patients with the extra edge that promotes their natural immunity. Clinical studies show that using a unique combination of three immune-enhancing nutrients: arginine, omega-3 fatty acids and dietary nucleotides-- results in fewer infectious complications, fewer days on a ventilator and shorter hospital stays. These enteral formulas can provide a significant impact on patient morbidity and overall health costs. |
 |
Res-Q Orosine Maintain Healthy Cell and Immune Function (2) Bottles 60 Capsules by Res-Q Res-Q Orosine is a breakthrough cell regeneration formula.Res-Q Orosine is the first product of its kind that works directly on the red blood cells to improve the delivery of oxygen to the heart, relax blood vessels and improve blood flow to the heart.Orosine restores the integrity of injured cells, including damaged heart cells, and minimizes further damage to those cells. Orosine benefits those seeking cardiovascular health both by prevention and post cardiac care. Orosine maintains organ health by rejuvenating and regenerating cells that are under stress of daily life. Orosine is also ideal for those who are on an exercise regimen as it helps improve exercise tolerance and endurance during exercise.,Res-Q has been granted the marketing rights for Orosine, this patented revolutionary... |
| © 2009 BrightSurf.com |